Inflammatory Biomarkers as Tool in Diagnosis and Management of Patients With Ischemic Stroke

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Stroke represents the third commonest cause of death after heart disease and all types of cancer combined, and is the leading cause of long-term permanent disability among adults. Recombinant tissue plasminogen activator (tPA) is currently the only safe medical treatment for acute ischemic stroke but only a small fraction of patients are eligible for a thrombolysis treatment. Current guidelines on thrombolysis...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 February 2013.

1 Feb 2013 6 Feb 2013 1 Aug 2013 Unavailable 1 Feb 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts